Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiolipin is a unique phospholipid, also known as diphosphatidylglycerol, predominantly found in the inner mitochondrial membrane of eukaryotic cells. It constitutes about 20% of the total lipid composition in this membrane and is especially abundant in tissues with high energy demands such as heart and skeletal muscle. It plays crucial roles in mitochondrial structure, electron transport chain function, and membrane dynamics. As an autoantigen, antibodies against cardiolipin are associated with increased risk of various thrombotic and obstetric complications. Dysfunctional cardiolipin metabolism is implicated in diseases like Barth syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiolipin.